source
- FDA issues final guidance on formal meeting types and timelines for drug and biologics sponsorsThe U.S. Food and Drug Administration released final guidance on August 13 that details the types of formal meetings sponsors can request during the development of new drugs and biologics. The doc…
- US and UK health systems both prioritize clinical care over community prevention, author warnsKyle Vanelli argues that the United States and United Kingdom health systems share a fundamental flaw: they default to biomedical, hospital-based interventions rather than community-based preventiv…